Allianz Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-16,168
Closed -$46K 2648
2020
Q1
$46K Sell
16,168
-22,124
-58% -$71.3K ﹤0.01% 2427
2019
Q4
$125K Sell
38,292
-353
-0.9% -$1.02K ﹤0.01% 2711
2019
Q3
$83K Sell
38,645
-80,796
-68% -$216K ﹤0.01% 2693
2019
Q2
$375K Sell
119,441
-17,840
-13% -$57.9K ﹤0.01% 2439
2019
Q1
$511K Sell
137,281
-217,366
-61% -$734K ﹤0.01% 2317
2018
Q4
$1.03M Sell
354,647
-14,328
-4% -$39.4K ﹤0.01% 2022
2018
Q3
$970K Sell
368,975
-195,059
-35% -$479K ﹤0.01% 2234
2018
Q2
$1.32M Sell
564,034
-370,051
-40% -$1.03M ﹤0.01% 2119
2018
Q1
$2.75M Sell
934,085
-28,183
-3% -$76.9K ﹤0.01% 1783
2017
Q4
$2.64M Buy
962,268
+21,180
+2% +$65.1K ﹤0.01% 1912
2017
Q3
$3.19M Buy
941,088
+146,817
+18% +$408K ﹤0.01% 1836
2017
Q2
$1.98M Sell
794,271
-24,792
-3% -$57K ﹤0.01% 1985
2017
Q1
$1.86M Sell
819,063
-57,413
-7% -$127K ﹤0.01% 2025
2016
Q4
$1.86M Buy
876,476
+394,938
+82% +$1.1M ﹤0.01% 2001
2016
Q3
$1.58M Buy
481,538
+110,369
+30% +$350K ﹤0.01% 2076
2016
Q2
$1.17M Buy
371,169
+39,455
+12% +$132K ﹤0.01% 2134
2016
Q1
$1.1M Buy
331,714
+150,479
+83% +$469K ﹤0.01% 2036
2015
Q4
$642K Sell
181,235
-15,460
-8% -$64.7K ﹤0.01% 2128
2015
Q3
$990K Sell
196,695
-475,617
-71% -$2.73M ﹤0.01% 1839
2015
Q2
$4.32M Sell
672,312
-881,338
-57% -$5.9M ﹤0.01% 1428
2015
Q1
$10.9M Sell
1,553,650
-963,150
-38% -$6.98M 0.01% 920
2014
Q4
$19.4M Buy
2,516,800
+998,239
+66% +$7.9M 0.02% 725
2014
Q3
$11.3M Buy
1,518,561
+88,635
+6% +$823K 0.01% 791
2014
Q2
$13.8M Buy
1,429,926
+776,415
+119% +$6.92M 0.02% 665
2014
Q1
$5.43M Sell
653,511
-53,039
-8% -$455K 0.01% 934
2013
Q4
$5.96M Buy
706,550
+138,403
+24% +$1.17M 0.01% 896
2013
Q3
$4.53M Buy
568,147
+118,920
+26% +$956K 0.01% 951
2013
Q2
$3.47M Buy
+449,227
New +$3.5M ﹤0.01% 1021

Other funds holding PDLI